Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin.
Gunderson LL, Winter KA, Ajani JA, Pedersen JE, Moughan J, Benson AB 3rd, Thomas CR Jr, Mayer RJ, Haddock MG, Rich TA, Willett CG.
J Clin Oncol. 2012 Dec 10;30(35):4344-51. doi: 10.1200/JCO.2012.43.8085. Epub 2012 Nov 13.
PMID:23150707
Risks of non-ovarian cancers in women with borderline ovarian tumor: a national cohort study in Sweden.
Dobilas A, Jansåker F, Li X, Sundquist K, Borgfeldt C.
BMC Cancer. 2023 Oct 9;23(1):951. doi: 10.1186/s12885-023-11453-6.
PMID:37807065
Practice-changing clinical trials in radiation oncology for gastrointestinal malignancies in 2021-2023.
Boustani J, Huguet F, Vendrely V.
Cancer Radiother. 2023 Dec;27(8):768-777. doi: 10.1016/j.canrad.2023.08.001. Epub 2023 Oct 26.
PMID:38415359
Radiotherapy in the management of rare gastrointestinal cancers: A systematic review.
Bellefkih FZ, Benchakroun N, Lalya I, Amaoui B, El Kacemi H, Acharki A, El Hfid M, El Mazghi A, Chekrine T, Bouchbika Z, Jouhadi H, Sahraoui S, Tawfiq N, Michalet M.
Cancer Radiother. 2023 Sep;27(6-7):622-637. doi: 10.1016/j.canrad.2023.06.010. Epub 2023 Jul 25.
PMID:37500390
Clarifying the PSA grey zone: The management of patients with a borderline PSA.
Ross T, Ahmed K, Raison N, Challacombe B, Dasgupta P.